SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-079227
Filing Date
2023-03-24
Accepted
2023-03-24 16:47:06
Documents
13
Period of Report
2023-03-24
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K d475596d8k.htm   iXBRL 8-K 30993
  Complete submission text file 0001193125-23-079227.txt   190911

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20230324.xsd EX-101.SCH 3869
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20230324_def.xml EX-101.DEF 13644
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20230324_lab.xml EX-101.LAB 22549
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20230324_pre.xml EX-101.PRE 14612
7 EXTRACTED XBRL INSTANCE DOCUMENT d475596d8k_htm.xml XML 5311
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 23760477
SIC: 2833 Medicinal Chemicals & Botanical Products